Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 26, 2019
Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective StudyFederica Sora, Carmen Di Grazia, Patrizia Chiusolo, et al.
Blood Advances|August 8, 2025
Routine Prophylaxis with Levetiracetam offers no benefit in CD19 CAR-T for LBCL: a Multicenter Propensity-matched StudyEugenio Galli, Roberta Di Blasi, Alice Di Rocco, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 9, 2018
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter StudyPatrizia Chiusolo, Gesine Bug, Attilio Olivieri, et al.
Bone Marrow Transplantation|August 18, 2024
Young (<35 years) haploidentical versus old (≥35 years) mismatched unrelated donors and vice versa for allogeneic stem cell transplantation with post-transplant cyclophosphamide in patients with acute myeloid leukemia in first remission: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
British Journal of Haematology|July 18, 2020
Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patientsSilvia Bellesi, Elisabetta Metafuni, Stefan Hohaus, et al.
Frontiers in Medicine|February 8, 2024
Acute graft versus host disease 1976-2020: reduced incidence and predictive factorsAlessandra Di Francesco, Anna Maria Raiola, Alida Dominietto, et al.
Bone Marrow Transplantation|May 13, 2025
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMTGiorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, et al.
Transplantation and Cellular Therapy|August 17, 2021
The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell TransplantationMario Delia, Paola Carluccio, Anna Mestice, et al.
Blood Advances|December 17, 2021
The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantationElisabetta Metafuni, Irene Maria Cavattoni, Teresa Lamparelli, et al.
Elife|April 2, 2024
Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity predictionSara Latini, Veronica Venafra, Giorgia Massacci, et al.
Pageof 20